NEW BIPHENYL COMPOUND OR ITS SALT Russian patent published in 2022 - IPC C07D207/14 C07D211/58 C07D471/10 A61K31/40 A61K31/4468 A61P35/00 

Abstract RU 2765152 C2

FIELD: medicine.

SUBSTANCE: invention relates to a compound of the formula (I) or its pharmaceutically acceptable salt, having inhibitory activity against LSD1, an LSD1inhibitor, a pharmaceutical composition and an antitumor agent based on them, a method for the treatment of a patient with acute human myelocytic leukemia and small cell lung cancer, as well as their use in the production of such an antitumor agent. In the general formula (I), ring A is a 5-9-element monocyclic, bridged cyclic or spirocyclic nitrogen-containing saturated heterocyclic group optionally additionally containing 1 nitrogen atom, ring B is phenyl or 9-element bicyclic aromatic heterocyclic group with 1-3 nitrogen atoms, R1 is nitro or cyano, R2 is halogen, R3 is unsubstituted amino, mono- or di(C1-C6 alkyl)amino, (C3-C7 cycloalkyl)amino or C1-C6 alkyl, R4 is halogen, unsubstituted C3-C7 cycloalkyl or C1-C8 alkyl, unsubstituted or substituted OH or cyclobutyl, R5 is hydrogen or C1-C6 alkyl, R6 is hydrogen, l is an integer from 0 to 1, m is an integer from 0 to 2, and n is an integer from 0 to 3, where if m is 2, two R3 can be the same or different, and if n is from 2 to 3, from two to three R4 can be the same or different.

EFFECT: provision of compounds of the formula (I) or their pharmaceutically acceptable salts with inhibitory activity against LSD1.

12 cl, 42 tbl, 300 ex

Similar patents RU2765152C2

Title Year Author Number
NEW BIPHENYL COMPOUND OR ITS SALT 2016
  • Yamashita, Satoshi
  • Ogawa, Takahiro
  • Komatani, Hideya
RU2726622C2
METHOD FOR PREDICTING THE THERAPEUTIC EFFECT OF AN LSD 1INHIBITOR BASED ON THE INSM1 EXPRESSION 2018
  • Hatanaka, Ryo
RU2789449C2
ANTITUMOR EFFECT ENHANCER USING NEW BIPHENYL COMPOUND 2018
  • Osada, Akiko
RU2765153C2
NOVEL NICOTINAMIDE DERIVATIVE OR ITS SALT 2011
  • Fudzivara Khidejasu
  • Midzumoto Sinsuke
  • Kubo Jokhei
  • Nakata Khijoku
  • Nagivara Sindzi
  • Baba Jasutaka
  • Tamura Takasi
  • Kunijosi Khidenobu
  • Masiko Tomojuki
  • Jamamoto Mari
RU2576623C2
NITRILE-CONTAINING ANTIVIRAL COMPOUNDS 2021
  • Ouen, Defidd Ris
  • Pettersson, Martin Yungchin
  • Riz, Mettyu Richard
  • Semmons, Mettyu Forrest
  • Tattl, Dzhejmison Brajs
  • Verkhust, Patrik Robert
  • Vej, Lyutsin
  • Yan, Syaotszin
  • Yan, Tsingyuj
RU2820150C2
NITRILE-CONTAINING ANTIVIRAL COMPOUNDS 2021
  • Owen, Dafydd Rhys
  • Pettersson, Martin Youngjin
  • Reese, Matthew Richard
  • Sammons, Matthew Forrest
  • Tuttle, Jamison Bryce
  • Verhoest, Patrick Robert
  • Wei, Liuqing
  • Yang, Xiaojing
  • Yang, Qingyi
RU2786722C1
DIPEPTIDYL PEPTIDASE-IV INHIBITORS 2010
  • Balasubramanian Gopalan
  • Sakamuri Sukumar
  • Singkh Gadzhendra
  • Dkharmalingam Sivanesan
  • Pooppadi Ksavier Franklin
  • Narajanan Shridkhar
  • Mookkan Dzhejamurugan
  • Balasubramanian Dzheganatkha Sivakumar
  • Radzhalingam Agneesvari
  • Kulatkhingal Dzhajanarajan
RU2574410C2
PROTEOLYSIS MODULATORS AND RELATED USES 2019
  • Crew, Andrew P.
  • Hornberger, Keith R.
  • Wang, Jing
  • Dong, Hanqing
  • Berlin, Michael
  • Crews, Craig M.
RU2805511C2
CHEMICAL COMPOUNDS 637: PYRIDOPYRIMIDINEDIONES AS PDE4 INHIBITORS 2008
  • Bonnert Rodzher Viktor
  • Burkamp Frank
  • Koks Rona Dzhejn
  • De Souza Sajmon
  • Dikkinson Mark
  • Khant Sajmon Frejzer
  • Megani Premdzhi
  • Pimm Osten
  • Sangani Khitesh Dzhajantilal
RU2479584C2
MENIN-MLL INTERACTION INHIBITORS 2017
  • Kakatyan Salvasion
  • Klejrmon Devid A.
  • Dillard Lourens Vejn
  • Dun Chengo
  • Fan I
  • Tszya Lantsi
  • Lotesta Stefen D.
  • Markus Endryu
  • Morales-Ramos Enzhel
  • Singkh Suresh B.
  • Venkatraman Shankar
  • Yuan Tszin
  • Chzhen Yatszyun
  • Chzhuan Linkhan
  • Perent Stefan D.
  • Khyuston Trejvis L.
RU2799820C2

RU 2 765 152 C2

Authors

Yamashita, Satoshi

Ogawa, Takahiro

Dates

2022-01-26Published

2018-05-25Filed